Yinglong Peng

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersInfectious diseasesNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 16, 2026
Impact of liver metastasis on the efficacy of first-line chemoimmunotherapy in extensive-stage small-cell lung cancer: a retrospective cohort study.

|Jan 06, 2026
Multiple Primary Lung Cancer With Driver Gene Mutations: Is Targeted Therapy Always the Optimal Choice?-A Case Report.

Zi-Rui Ren, Lv Wu, Chang Lu

|Jun 09, 2025
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer.

Li-Bo Tang, Ying-Long Peng, Ji Chen

|Jan 23, 2024
Association of COVID-19 and Lung Cancer: Short-Term and Long-Term Interactions.

Ying-Long Peng, Zi-Yan Wang, Ri-Wei Zhong

|Mar 11, 2023
The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.

Ziyan Wang, Yinglong Peng, Minshan Chen

|Aug 26, 2022
<i>Helicobacter</i><i>pylori</i> Infection-A Risk Factor for Irritable Bowel Syndrome? An Updated Systematic Review and Meta-Analysis.

Ziyan Wang, Yuhua Liu, Yinglong Peng

Pageof 1

Frequent Collaborators

3 joint publications

Ziyan Wang

3 joint publications

Chong-Rui Xu

2 joint publications

Li-Bo Tang

2 joint publications

Liang Peng